Literature DB >> 33199162

Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018.

Taeho Greg Rhee1, Donovan T Maust2, David A Fiellin3, Mark Olfson4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33199162      PMCID： PMC7902367          DOI： 10.1016/j.amepre.2020.09.007

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN： 0749-3797            Impact factor:   5.043


× No keyword cloud information.
  6 in total

1.  Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.

Authors:  Taeho Greg Rhee
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

2.  Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017.

Authors:  Aishwarya Vijay; Joseph S Ross; Nilay D Shah; Molly M Jeffery; Sanket S Dhruva
Journal:  J Gen Intern Med       Date:  2019-04       Impact factor: 5.128

3.  Food and Drug Administration Requires Strong Warnings for Opioid Analgesics, Prescription Opioid Cough Products, and Benzodiazepine Labeling Related to Serious Risks and Death From Combined Use.

Authors: 
Journal:  J Pain Palliat Care Pharmacother       Date:  2016-12

4.  Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.

Authors:  Victoria Shu Zhang; Mark Olfson; Marissa King
Journal:  JAMA Psychiatry       Date:  2019-11-01       Impact factor: 21.596

5.  Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.

Authors:  Catherine S Hwang; Elizabeth M Kang; Cynthia J Kornegay; Judy A Staffa; Christopher M Jones; Jana K McAninch
Journal:  Am J Prev Med       Date:  2016-04-11       Impact factor: 5.043

6.  Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016.

Authors:  Nathan J Pauly; Chris Delcher; Svetla Slavova; Eric Lindahl; Jeff Talbert; Patricia R Freeman
Journal:  J Manag Care Spec Pharm       Date:  2020-03
  6 in total
  3 in total

1.  New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery.

Authors:  Jacob C Cogan; Rohit R Raghunathan; Melissa P Beauchemin; Melissa K Accordino; Elena B Elkin; Alexander Melamed; Jason D Wright; Dawn L Hershman
Journal:  Breast Cancer Res Treat       Date:  2021-06-04       Impact factor: 4.872

2.  Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018.

Authors:  Lauren R Gorfinkel; Deborah Hasin; Andrew J Saxon; Melanie Wall; Silvia S Martins; Magdalena Cerdá; Katherine Keyes; David S Fink; Salomeh Keyhani; Charles C Maynard; Mark Olfson
Journal:  J Pain       Date:  2022-02-08       Impact factor: 5.383

3.  Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare.

Authors:  Lianlian Lei; Julie Pw Bynum; Donovan T Maust
Journal:  Am J Geriatr Psychiatry       Date:  2021-08-28       Impact factor: 4.105
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.